Novo Nordisk Finds Relief as Rival’s Production Woes and Buyback Bolster Recovery
Novo Nordisk shares have climbed more than 43% from their March nadir, riding a recovery that now draws…
Novo Nordisk Finds a Few Bright Spots as Its Pipeline Takes Centre Stage
Novo Nordisk is trying to turn the spotlight away from weaker near-term trading and toward what comes next.…